Close

Aravive to Participate in the Cantor Fitzgerald Oncology & HemOnc Conference Sep 26, 2022 08:00AM
Cantor Fitzgerald Reiterates Overweight Rating, $18 Price Target on Aravive (ARAV), "Peak Sales Potential of AVB-500 Remains Underappreciated" May 12, 2022 09:44AM
Aravive to Participate in Fireside Chat at Cantor Fitzgerald Virtual Global Healthcare Conference Sep 16, 2021 07:00AM
Aravive to Participate in Upcoming Virtual Investor Conferences in September Sep 8, 2020 07:00AM
Cantor Fitzgerald Reiterates Overweight Rating on Aravive Inc. (ARAV) Feb 24, 2020 07:04AM


Dec 9, 2019 04:06PM Cantor Fitzgerald Starts Aravive Inc. (ARAV) at Overweight
Nov 27, 2019 08:31AM Aravive Inc. (ARAV) Prices 3.33M Share Common Offering at $7.50/Sh
Nov 27, 2019 08:30AM Aravive Announces Pricing of Public Offering of Common Stock
Nov 26, 2019 05:14PM Aravive Inc. (ARAV) Plans Public Offering of Common Stock
Nov 26, 2019 05:14PM Aravive Announces Proposed Public Offering of Common Stock